Kailera Therapeutics, Inc. Common Stock (KLRA) — Defensive Interval Ratio
Kailera Therapeutics, Inc. Common Stock (KLRA) has a Defensive Interval Ratio of 2711 days as of March 2026. Defensive assets of $407.35 Million (cash $-, short-term investments $407.35 Million, receivables $-) cover 2711 days of daily cash needs of $150.24K/day. See Kailera Therapeutics, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Kailera Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Kailera Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at 2711 days, meaning defensive assets of $407.35 Million can fund 2711 days of operations without new revenue. See Kailera Therapeutics, Inc. Common Stock balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Kailera Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Kailera Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see KLRA company net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3034 days | $385.79 Million | $127.14K/day | $- | $385.79 Million | ▲ +3034 days |
| 2024 | 0 days | $0.00 | $18.93K/day | $- | $0.00 | — |